2025年2月12日 · What is febuxostat? Febuxostat reduces the production of uric acid in your body. A build-up of uric acid can cause gout symptoms. Febuxostat is used to keep uric acid levels from getting to high in people with gout. Febuxostat is for use only in people who cannot take another medicine called allopurinol, or when allopurinol has stopped working.

2024年6月13日 · Febuxostat is commonly used to treat gout, which is a form of arthritis caused by too much uric acid in your blood and joints. Febuxostat may be used when another medicine for gout, allopurinol...

Febuxostat, sold under the brand name Uloric among others, is a medication used long-term to treat gout due to high uric acid levels. [7] It is generally recommended only for people who cannot take allopurinol .

2024年3月28日 · Learn about the side effects of febuxostat, from common to rare, for consumers and healthcare professionals.

2025年2月1日 · Febuxostat is used to lower hyperuricemia (high uric acid in the blood) in patients with gout who have been treated with allopurinol that did not work well or cannot be treated with allopurinol. This medicine is a xanthine oxidase inhibitor.

2019年5月30日 · Febuxostat oral tablet is a prescription medication used to treat hyperuricemia (high levels of uric acid) in adults with gout. It helps decrease symptoms of gout.

2019年11月22日 · Febuxostat is a non-purine selective inhibitor of the enzyme xanthine oxidase and is FDA-approved for the chronic management of hyperuricemia in patients diagnosed with gout.

What is febuxostat and how is it used? Taken regularly, febuxostat can prevent damage to your joints, stop attacks of gout and reduce the size of gouty lumps affecting your skin. The body naturally produces a substance called urate, which normally dissolves in …

2025年2月17日 · Detailed Febuxostat dosage information for adults. Includes dosages for Gout; plus renal, liver and dialysis adjustments.

Febuxostat is a prescription medication used to treat Chronic Gout. Learn about side effects, dosages, drug interactions, and more.